Publications SMA12-4682
Print This Page Bookmark and Share
An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

SAMHSA Advisory, Winter 2012

Add To Favorites

Advisory - In Stock

Average Rating: 4 out of 20 ratings.
Comments
Price: FREE (shipping charges may apply)

Standard shipping is free. Expedited delivery has associated costs. You will be able to review shipping options and costs during check-out.


Gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.



Pub id: SMA12-4682
Publication Date: 2/2012
Popularity: 70
Format: Advisory
Audience: Professional Care Providers
Series: SAMHSA Advisory

You May Also Be Interested In

Related Resources

1 - 4 of 665
View All Related Resources
How to Suggest a New Link

Write a Comment

Fields marked with an * are required.

com.iqsolutions.pinnacle.dto.user.MyAccountDtoImpl@7f942283


For any questions regarding product availability or ordering methods, please review our Help Page . To be considered for public posting, comments should be geared towards helping visitors assess the quality of this content, and must adhere to the HHS Comment Policy.


Type the case-sensitive characters you see in the picture below.


Customer Comments

Comment by:

02/27/2012 9:45 AM

Anonymous customer said:

Great resource!

Comment by:

03/05/2012 6:42 PM

Anonymous customer said:

good inormation

Comment by:

03/19/2012 2:48 PM

Anonymous customer said:

This Advisory is helpful.

Comment by:

07/16/2012 4:09 PM

A professional from a Behavioral Health Treatment Facility said:

Thank you for the information which I am sure will help us with our attempt to implement the usage of Vivitrol in our programs